Technosphere Insulin (Afrezza): A New, Inhaled Prandial Insulin.

CONCLUSION: TI is a novel inhaled insulin that provides prandial coverage to patients with diabetes, representing an alternative to bolus insulin injections.
PMID: 25313261 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - October 13, 2014 Category: Drugs & Pharmacology Authors: Nuffer W, Trujillo JM, Ellis SL Tags: Ann Pharmacother Source Type: research